Stabilizing cold-adapted influenza virus vaccine under various storage conditions

Journal of Virological Methods

Volumn 102, Issue 1-2, 2002, Pages 15-25

  Yannarell, Dean A ^a   Goldberg, Kenneth M ^a   Hjorth, Richard N ^b  

^a WYETH AYERST RESEARCH   (United States)

^b Wyeth Lederle Vaccines and Pediat   (United States)

Author keywords

Casitone; Cold adapted; Frozen; Influenza; Lyophilized; Stability; Storage

Indexed keywords

CASITONE; DRUG ADDITIVE; GLUTAMIC ACID; INFLUENZA VACCINE; PHOSPHATE; STABILIZING AGENT; SUCROSE; UNCLASSIFIED DRUG;

AMNION FLUID; ARTICLE; COLD; DRUG FORMULATION; DRUG MARKETING; DRUG STABILITY; DRUG STORAGE; FREEZE DRYING; INFLUENZA VACCINATION; INFLUENZA VIRUS; LYOPHILISATE; PH; PRIORITY JOURNAL; ROOM TEMPERATURE; STORAGE TEMPERATURE;

ADAPTATION, PHYSIOLOGICAL; COLD; DRUG STORAGE; HUMANS; HYDROGEN-ION CONCENTRATION; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN;

INFLUENZA VIRUS;

EID: 0036186025     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(01)00432-3     Document Type: Article

References (32)

1. Renewed control efforts emphasize 'unrecognized' influenza threat
2. Comparison of the virologic and immunologic responses of volunteers to live avian-human influenza A H3N2 reassortant virus vaccines derived from two different avian influenza virus donors
3. Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83-like viruses
4. Stability characteristics of freeze-dried human live virus vaccines
5. Comparative studies of wild-type and cold-mutant (temperature-sensitive) influenza viruses: Nonrandom reassortment of genes during preparation of live virus vaccine candidates by recombination at 25°C between recent H3N2 and H1N1 epidemic strains and cold-adapted A/Ann Arbor/6/60
6. Pilot studies on recombinant cold-adapted live type A and B influenza virus vaccines
7. Safety and immunogenicity of live attenuated cold-adapted influenza B/Ann Arbor/1/86 reassortant virus vaccine in infants and children
8. Factors affecting immunization rate in a cohort of elderly veterans: A retrospective pilot study of influenza vaccine compliance
9. Immune response to influenza vaccination of elderly people. A randomized double-blind placebo-controlled trial
10. The effects on biological materials of freezing and drying by vacuum sublimation. II. Effect on influenza virus
11. An accelerated storage test for predicting the stability of suspensions of measles virus dried by sublimation in vacuo
12. Stability of suspensions of influenza virus dried to different contents of residual moisture by sublimation in vacuo
13. Stabilities of viruses following freezing and storage at low temperatures
14. Comparative trial of large-particle aerosol and nose drop administration of live attenuated influenza vaccines
15. Influenza vaccines and the Wyeth-Ayerst experience with Syntex adjuvant
16. Resistance to physical and chemical agents
17. Immunity to influenza A virus infection in young children: A comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine
18. Beitrag zur kollektiver behandlung pharmokologischer reihenversuche
19. New vaccine development: Establishing priorities
20. Adaptation and growth characteristics of influenza viruses at 25°C
21. Biologic and immunologic characteristics of cold-adapted influenza viruses
22. Development and characterization of cold-adapted viruses for use as live virus vaccines
23. Influenza - A preventable disease not being prevented
24. Freeze-drying of influenza virus
25. Stability of live, freeze-dried virus vaccines
26. The effect of low temperatures on vaccines of influenza virus and on purified influenza virus
27. Variation in influenza viruses. A study of heat stability of the red cell agglutinating factor
28. Safety of casein hydrolysate formula in children with cow milk allergy
29. The avian influenza virus nucleoprotein gene and a specific constellation of avian and human virus polymerase genes each specify attenuation of avian-human influenza A/Pintail/79 reassortant viruses for monkeys
30. Comparison of live attenuated cold-adapted and avian-human influenza A/Bethesda/85 (H3N2) reassortant virus vaccines in infants and children
31. Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly
32. Factors affecting the yield of cold-adapted influenza virus vaccine